Concert Pharma Misses Q1 EPS by 12c

  • Investing.com
Concert Pharma Misses Q1 EPS by 12c

Concert Pharma (NASDAQ: CNCE ) reported Q1 EPS of ($1.03), $0.12 worse than the analyst estimate of ($0.91).

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100